HubSpot (HUBS) Q2 2026 Earnings Call Transcript
HubSpot reported Q2 2026 revenue of $911.7M, up 20% year over year, with subscription revenue of $894.0M. Non-GAAP operating margin was 20.3% and non-GAAP free cash flow $167.9M. Net customer additions were 7,000 and total customers 306,446. FY2026 guidance: revenue $3.678B to $3.686B and non-GAAP EPS $13.23 to $13.31.
How this was made
The 30-second read
Why it matters
Traders can update models using the provided guidance ranges and KPI shifts (net customer additions below expected, NRR down, longer sales cycles) alongside capital return (repurchase authorization).
Market read
The combination of fresh guidance, NRR decline, and explicit buyback authorization makes this a direct input to near-term valuation and positioning for HUBS.
What to watch
The call highlights credit consumption rising despite lower entry prices, which could affect future unit economics and margin trajectory beyond the stated operating margin outlook.
Background
HubSpot’s Q2 2026 earnings call discusses AI agent adoption, changes to pricing/trials, and updated guidance for FY2026 and Q3.
Ticker impact
HubSpot reported Q2 results and guided FY2026 revenue to $3.678B-$3.686B, with Q3 revenue guidance of $924M-$925M.
Likely choppy reaction risk: upside from buybacks and margin/FCF, offset by below-expected net customer additions and NRR decline.
The article includes multiple decision-grade datapoints: FY2026 and Q3 revenue/EPS guidance ranges, net customer additions below expected, NRR down 1 point, and explicit commentary on slower deal cycles and upgrade pressure.
Market effects
Signals to CRM/marketing automation peers that AI agent trials and outcome-based pricing can extend sales cycles and pressure NRR even as adoption rises.
Primarily US large-cap software sentiment; may influence broader risk appetite for growth SaaS around earnings season.
Limited direct global macro linkage, but AI monetization and enterprise buying-cycle dynamics are broadly relevant to international SaaS investors.
Counterpoint
NRR and net additions softness may be temporary from trial-based pricing and larger buying committees, while upmarket growth and agent adoption could re-accelerate upgrades later.
Key entities
- companyHubSpot
Reported Q2 2026 results and provided FY2026 and Q3 2026 guidance, plus commentary on AI agent trials and net revenue retention pressure.
- executiveYamini Rangan
CEO who attributed slower deal cycles to trials and larger buying committees requiring more approvals.
- executiveKathryn Bueker
CFO who discussed net new ARR growth expectations and margin/FCF outlook.
